ViCentra has developed an insulin pump for diabetes patients.
ViCentra has raised €159M across 4 funding rounds from 10 investors, most recently a Series D+ round in Jan 2026. Based in Utrecht, Netherlands; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-01-08 | Series D+ | €11M | Dutch investors,Innovation Industries,ROM Utrecht Region,Venturing Tech | View deal → |
| 2025-09-04 | Series D+ | €73M | EQT Life Sciences,Health Innovations,Innovation Industries,Invest-NL,Partners in Equity | View deal → |
| 2021-12-16 | Series C | €65M | Health Innovations,INKEF Capital,LSP,Partners in Equity | View deal → |
| 2020-07-09 | Other | €10M | Invest-NL | View deal → |
